Status:
COMPLETED
ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin Reloading
Lead Sponsor:
Gennaro Sardella
Conditions:
Assess the Periprocedural Myocardial Necrosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
An increase in cardiac biomarkers has been shown to occur in 5% to 30% of patients after otherwise successful percutaneous coronary interventions (PCIs)(1) Apart from side-branch occlusion, intimal di...
Eligibility Criteria
Inclusion
- Patients with stable angina
Exclusion
- Baseline myocardial enzyme rise
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT01228227
Start Date
October 1 2010
End Date
August 1 2011
Last Update
January 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico Umberto I
Roma, Roma, Italy